about
Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncolo...
Read More
22.44
0.25
(1.13%)
625.7K
XNAS Volume
XNAS 08 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Immunome Inc is on 12 May 2026 for the purpose of Immunome Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Immunome Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..